Development of a Miniaturized, Pediatric Continuous-Flow Total Artificial Heart with a Single Moving Part

开发具有单个移动部件的小型化儿科连续流动全人工心脏

基本信息

  • 批准号:
    9901602
  • 负责人:
  • 金额:
    $ 74.71万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-04-01 至 2022-02-28
  • 项目状态:
    已结题

项目摘要

Project Summary Mechanical circulatory support (MCS) is already a standard therapy in adult patients with end-stage heart failure. In pediatric patients with congenital heart diseases (CHDs), however, no implantable devices are currently available. Congenital anomalies in pediatric patients can make it difficult to use ventricular assist devices (VADs) to sustain hemodynamics. While heart transplantation can be an ideal therapy, donor hearts suitable for small children are very limited. Although total artificial heart (TAH) is an alternative for complex cardiac anomalies, no pediatric TAHs exist, other than SynCardia's 50cc Total Artificial Heart that is under investigational device exemption clinical study. This device is smaller than their regular 70cc TAH but is intended only for patients with a body surface area (BSA) of ≥ 1.2 m2, i.e., that of an average 11-year-old. The goal of this proposal is to develop a pediatric TAH based on Cleveland Clinic’s continuous-flow TAH (CFTAH), designed for use in adult patients (R01HL096619). Similar to the adult CFTAH, this pediatric CFTAH (P- CFTAH) is designed with one motor and one rotating assembly supported by a hydrodynamic bearing; it is valveless and sensorless and has the ability to produce pulsatile flow, self-balance left and right circulation without electronic intervention, and control speed automatically. Chronic animal experiments of the adult CFTAH have demonstrated stable hemodynamics and good biocompatibility for 3 months. It was possible to reduce the size of this CFTAH to 30% smaller in diameter (3.5 cm) and 30% shorter in the length (4.8 cm) with 1/3 of the total device volume, such that it can be implanted in the chest of most infants whose BSA is ≥ 0.3 m2. The pump flow range of 1.5-4.5 L/min will support patients weighing up to 50 kg (the average weight of 14- year-old children). For destination therapy, when the patient grows beyond the requirement of 4.5 L/min, the P-CFTAH can be replaced by the adult CFTAH, by disconnecting the inflow and outflow ports of the P-CFTAH from their respective inflow cuffs and outflow grafts and connecting a new adult CFTAH under cardiopulmonary bypass. The Specific Aims to achieve this goal are: (1) Refine our initial P-CFTAH prototype device for hydraulic performance and biocompatibility by using validated computational fluid dynamics analysis, and include new manufacturing improvements, which are also being applied to the adult CFTAH, (2) Perform intraoperative fitting studies to confirm the smallest patient size and critical dimensions to determine fitting requirements, (3) Perform in vitro system characterization, hemolysis testing, and endurance testing to verify that the P-CFTAH meets requirements for system performance, and (4) Perform acute and chronic in vivo experiments to validate hemodynamic response, the self-regulating mechanical design, system performance, and biocompatibility. The successful completion of this program will demonstrate the feasibility of this approach applied to a P-CFTAH and ultimately provide clinicians and pediatric patients with a valuable treatment option for heart failure.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kiyotaka Fukamachi其他文献

Kiyotaka Fukamachi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kiyotaka Fukamachi', 18)}}的其他基金

Development of a Miniaturized, Pediatric Continuous-Flow Total Artificial Heart with a Single Moving Part
开发具有单个移动部件的小型化儿科连续流动全人工心脏
  • 批准号:
    10115789
  • 财政年份:
    2018
  • 资助金额:
    $ 74.71万
  • 项目类别:
Advanced Ventricular Assist Device with Pulse Augmentation and Automatic Regurgitant Flow Shutoff
具有脉冲增强和自动回流关闭功能的先进心室辅助装置
  • 批准号:
    9313928
  • 财政年份:
    2016
  • 资助金额:
    $ 74.71万
  • 项目类别:
Self Regulating Continuous Flow Total Artificial Heart
自调节连续流全人工心脏
  • 批准号:
    8449612
  • 财政年份:
    2010
  • 资助金额:
    $ 74.71万
  • 项目类别:
Self-regulating continuous-flow total artificial heart
自调节连续流全人工心脏
  • 批准号:
    9316685
  • 财政年份:
    2010
  • 资助金额:
    $ 74.71万
  • 项目类别:
Mitral Annular Remodeling for MR Therapy
MR 治疗的二尖瓣环重塑
  • 批准号:
    6959620
  • 财政年份:
    2005
  • 资助金额:
    $ 74.71万
  • 项目类别:
Development and Clinical Testing of CorAide RVAD/BVAD
CorAide RVAD/BVAD 的开发和临床测试
  • 批准号:
    6931173
  • 财政年份:
    2004
  • 资助金额:
    $ 74.71万
  • 项目类别:
Development and Clinical Testing of CorAide RVAD/BVAD
CorAide RVAD/BVAD 的开发和临床测试
  • 批准号:
    7070596
  • 财政年份:
    2004
  • 资助金额:
    $ 74.71万
  • 项目类别:
Development and Clinical Testing of CorAide RVAD/BVAD
CorAide RVAD/BVAD 的开发和临床测试
  • 批准号:
    7255600
  • 财政年份:
    2004
  • 资助金额:
    $ 74.71万
  • 项目类别:
Development and Clinical Testing of CorAide RVAD/BVAD
CorAide RVAD/BVAD 的开发和临床测试
  • 批准号:
    6993173
  • 财政年份:
    2004
  • 资助金额:
    $ 74.71万
  • 项目类别:
Development and Clinical Testing of CorAide RVAD/BVAD
CorAide RVAD/BVAD 的开发和临床测试
  • 批准号:
    7450773
  • 财政年份:
    2004
  • 资助金额:
    $ 74.71万
  • 项目类别:

相似海外基金

More compassion, better grades? A Mixed Method study on the effects of Mindfulness onProsocial Behaviour and Academic Performance in 7 to 11 year old
更多同情心,更好的成绩?
  • 批准号:
    2272665
  • 财政年份:
    2019
  • 资助金额:
    $ 74.71万
  • 项目类别:
    Studentship
The Strong Families Trial: Randomised controlled trial of a family strengthening program to prevent unhealthy weight gain among 5- to 11-year old children from at risk families
坚强家庭试验:家庭强化计划的随机对照试验,旨在防止来自高危家庭的 5 至 11 岁儿童体重不健康增加
  • 批准号:
    nhmrc : 1138403
  • 财政年份:
    2018
  • 资助金额:
    $ 74.71万
  • 项目类别:
    Project Grants
The Strong Families Trial: Randomised controlled trial of a family strengthening program to prevent unhealthy weight gain among 5- to 11-year old children from at risk families
坚强家庭试验:家庭强化计划的随机对照试验,旨在防止来自高危家庭的 5 至 11 岁儿童体重不健康增加
  • 批准号:
    nhmrc : GNT1138403
  • 财政年份:
    2018
  • 资助金额:
    $ 74.71万
  • 项目类别:
    Project Grants
How Independent Mobility Influences Outdoor Active Play among 8-11 year old children.
独立活动如何影响 8-11 岁儿童的户外活动。
  • 批准号:
    324332
  • 财政年份:
    2015
  • 资助金额:
    $ 74.71万
  • 项目类别:
Television Viewing and Food Intake Patterns of Lean and Overweight/Obese 9-11 year-old Canadian Children
9-11 岁瘦和超重/肥胖加拿大儿童的电视观看和食物摄入模式
  • 批准号:
    294319
  • 财政年份:
    2013
  • 资助金额:
    $ 74.71万
  • 项目类别:
Effect of in-shoe foot orthoses on gait, motor skills & foot pain for 7-11 year old children with flat feet
鞋内足部矫形器对步态、运动技能的影响
  • 批准号:
    nhmrc : 991323
  • 财政年份:
    1999
  • 资助金额:
    $ 74.71万
  • 项目类别:
    NHMRC Project Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了